Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Lucherini OM, Vitale A, Obici L, Sota J, Frediani B, Merlini G, Rigante D, Cantarini L.

Clin Exp Rheumatol. 2019 May 30. [Epub ahead of print] No abstract available.

PMID:
31172924
2.

Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.

Lucherini OM, Vitale A, Orlando I, Sota J, Fabiani C, Franceschini R, Simpatico A, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):110-115. Epub 2018 Dec 12.

PMID:
30582507
3.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
4.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

5.

Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.

Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, Gattorno M, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):3-9. Epub 2018 May 3. Review.

6.

Trapped crystals in synovial fluid: neutrophil extracellular traps from bench to bedside.

Garcia-Gonzalez E, Lucherini OM, Gamberucci A, Alì A, Simpatico A, Lorenzini S, Galeazzi M, Selvi E.

Rheumatology (Oxford). 2018 Apr 1;57(4):759-760. doi: 10.1093/rheumatology/kex502. No abstract available.

PMID:
29385560
7.

IL-6 blockade in the management of non-infectious uveitis.

Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20. Review.

PMID:
28528519
8.

Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Cantarini L, Pucino V, Vitale A, Lucherini OM, Obici L, Matarese G.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):13-14. Epub 2017 Apr 4. No abstract available.

9.

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.

Lopalco G, Lucherini OM, Lopalco A, Venerito V, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Cantarini L, Iannone F.

Front Immunol. 2017 Feb 27;8:200. doi: 10.3389/fimmu.2017.00200. eCollection 2017.

10.

The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy.

Vitale A, Rigante D, Lucherini OM, De Palma A, Orlando I, Gentileschi S, Sota J, Simpatico A, Fabiani C, Galeazzi M, Frediani B, Cantarini L.

Intern Emerg Med. 2017 Aug;12(5):605-611. doi: 10.1007/s11739-017-1622-z. Epub 2017 Feb 13.

PMID:
28194697
11.

Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study.

Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, Maggio C, Obici L, Gallizi R, Cimmino M, Signa S, Lucherini OM, Carta S, Caroli F, Martini A, Rubartelli A, Ceccherini I, Gattorno M.

J Rheumatol. 2016 Jun;43(6):1093-100. doi: 10.3899/jrheum.150962. Epub 2016 Apr 1.

PMID:
27036377
12.

Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.

Cantarini L, Pucino V, Vitale A, Talarico R, Lucherini OM, Magnotti F, De Rosa V, Galgani M, Alviggi C, Marone G, Galeazzi M, Matarese G.

Clin Exp Immunol. 2016 May;184(2):197-207. doi: 10.1111/cei.12768. Epub 2016 Feb 24.

13.

Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.

Pucino V, Lucherini OM, Perna F, Obici L, Merlini G, Cattalini M, La Torre F, Maggio MC, Lepore MT, Magnotti F, Galgani M, Galeazzi M, Marone G, De Rosa V, Talarico R, Cantarini L, Matarese G.

J Leukoc Biol. 2016 May;99(5):761-9. doi: 10.1189/jlb.3A0915-399R. Epub 2015 Nov 23.

PMID:
26598380
14.

Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.

Lopalco G, Lucherini OM, Vitale A, Talarico R, Lopalco A, Galeazzi M, Lapadula G, Cantarini L, Iannone F.

Medicine (Baltimore). 2015 Oct;94(42):e1858. doi: 10.1097/MD.0000000000001858.

15.

The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study.

Marrani E, Cimaz R, Lucherini OM, Caputo R, Vitale A, Cantarini L, Simonini G.

Pediatr Rheumatol Online J. 2015 Oct 6;13(1):38. doi: 10.1186/s12969-015-0037-5.

16.

Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes.

Cheleschi S, Cantarini L, Pascarelli NA, Collodel G, Lucherini OM, Galeazzi M, Fioravanti A.

Cytokine. 2015 Feb;71(2):165-72. doi: 10.1016/j.cyto.2014.10.023. Epub 2014 Nov 17.

PMID:
25461395
17.

The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls, De Pieri et al.

Vitale A, Rigante D, Lucherini OM, Caso F, Cantarini L.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):994. Epub 2014 Oct 20. No abstract available.

PMID:
25327451
18.

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.

Autoimmun Rev. 2014 Dec;13(12):1220-9. doi: 10.1016/j.autrev.2014.08.010. Epub 2014 Aug 23. Review.

PMID:
25182201
19.

The hereditary autoinflammatory disorders uncovered.

Rigante D, Vitale A, Lucherini OM, Cantarini L.

Autoimmun Rev. 2014 Sep;13(9):892-900. doi: 10.1016/j.autrev.2014.08.001. Epub 2014 Aug 20. Review.

PMID:
25149390
20.

Untangling the web of systemic autoinflammatory diseases.

Rigante D, Lopalco G, Vitale A, Lucherini OM, Caso F, De Clemente C, Molinaro F, Messina M, Costa L, Atteno M, Laghi-Pasini F, Lapadula G, Galeazzi M, Iannone F, Cantarini L.

Mediators Inflamm. 2014;2014:948154. doi: 10.1155/2014/948154. Epub 2014 Jul 15. Review.

21.

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martín L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L.

Mediators Inflamm. 2014;2014:107421. doi: 10.1155/2014/107421. Epub 2014 Jun 30. Review.

22.

The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.

Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L, Emmi G, Silvestri E, Magnotti F, Maggio MC, Prinzi E, Lopalco G, Frediani B, Cimaz R, Galeazzi M, Rigante D.

Clin Rheumatol. 2015 Jan;34(1):17-28. doi: 10.1007/s10067-014-2721-0. Epub 2014 Jun 24. Review.

PMID:
24953660
23.

Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Rigante D, Lopalco G, Vitale A, Lucherini OM, De Clemente C, Caso F, Emmi G, Costa L, Silvestri E, Andreozzi L, Iannone F, Galeazzi M, Cantarini L.

Clin Rheumatol. 2014 Sep;33(9):1197-207. doi: 10.1007/s10067-014-2722-z. Epub 2014 Jun 17. Review.

PMID:
24935411
24.

Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.

Cantarini L, Lopalco G, Vitale A, Coladonato L, Rigante D, Lucherini OM, Lapadula G, Iannone F.

Clin Rheumatol. 2015 Jun;34(6):1141-3. doi: 10.1007/s10067-014-2589-z. Epub 2014 Apr 15.

PMID:
24733249
25.

Efficacy of anakinra in refractory Behçet's disease sacroiliitis.

Caso F, Rigante D, Vitale A, Lucherini OM, Cantarini L.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S171. Epub 2014 Apr 7. No abstract available.

PMID:
24709061
26.

Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series.

Vitale A, Rigante D, Caso F, Brizi MG, Galeazzi M, Costa L, Franceschini R, Lucherini OM, Cantarini L.

Dermatology. 2014;228(3):211-4. doi: 10.1159/000358125. Epub 2014 Mar 12.

PMID:
24642905
27.

Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc.

Patrussi L, Capitani N, Cannizzaro E, Finetti F, Lucherini OM, Pelicci PG, Baldari CT.

Cell Death Dis. 2014 Feb 20;5:e1068. doi: 10.1038/cddis.2014.44.

28.

Specific recycling receptors are targeted to the immune synapse by the intraflagellar transport system.

Finetti F, Patrussi L, Masi G, Onnis A, Galgano D, Lucherini OM, Pazour GJ, Baldari CT.

J Cell Sci. 2014 May 1;127(Pt 9):1924-37. doi: 10.1242/jcs.139337. Epub 2014 Feb 19.

29.

Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

La Torre F, Lapadula G, Cantarini L, Lucherini OM, Iannone F.

Clin Rheumatol. 2015 Feb;34(2):391-5. doi: 10.1007/s10067-014-2493-6. Epub 2014 Jan 21. Review.

PMID:
24445386
30.

The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.

Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM, Sfriso P, Frediani B, Punzi L, Galeazzi M, Cimaz R, Obici L.

Semin Arthritis Rheum. 2014 Jun;43(6):818-23. doi: 10.1016/j.semarthrit.2013.12.002. Epub 2013 Dec 12.

PMID:
24393624
31.

Weekly oral alendronate in mevalonate kinase deficiency.

Cantarini L, Vitale A, Magnotti F, Lucherini OM, Caso F, Frediani B, Galeazzi M, Rigante D.

Orphanet J Rare Dis. 2013 Dec 20;8:196. doi: 10.1186/1750-1172-8-196.

32.

Anakinra treatment in drug-resistant Behcet's disease: a case series.

Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, Simonini G, Borsari G, Caso F, Lucherini OM, Frediani B, Bertoldi I, Punzi L, Galeazzi M, Cimaz R.

Clin Rheumatol. 2015 Jul;34(7):1293-301. doi: 10.1007/s10067-013-2443-8. Epub 2013 Dec 5.

PMID:
24305945
33.

Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

Caso F, Rigante D, Vitale A, Lucherini OM, Costa L, Atteno M, Compagnone A, Caso P, Frediani B, Galeazzi M, Punzi L, Cantarini L.

Int J Rheumatol. 2013;2013:513782. doi: 10.1155/2013/513782. Epub 2013 Oct 24. Review.

34.

Working the endless puzzle of hereditary autoinflammatory disorders.

Caso F, Cantarini L, Lucherini OM, Sfriso P, Fioretti M, Costa L, Vitale A, Atteno M, Galeazzi M, Muscari I, Magnotti F, Frediani B, Punzi L, Rigante D.

Mod Rheumatol. 2014 May;24(3):381-9. doi: 10.3109/14397595.2013.843755. Epub 2013 Oct 18. Review.

PMID:
24251993
35.

Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series.

Vitale A, Rigante D, Maggio MC, Emmi G, Romano M, Silvestri E, Lucherini OM, Emmi L, Gerloni V, Cantarini L.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):155-6. Epub 2013 Sep 9. No abstract available.

PMID:
24064030
36.

First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G, Muscari I, Magnotti F, Dickie LJ, Galeazzi M, Negrini M, Baldari CT, Cimaz R, Cantarini L.

PLoS One. 2013 Sep 16;8(9):e73443. doi: 10.1371/journal.pone.0073443. eCollection 2013.

37.

Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F, Brizi MG, Guerrini S, Patti M, Punzi L, Galeazzi M, Cantarini L.

Mediators Inflamm. 2013;2013:939847. doi: 10.1155/2013/939847. Epub 2013 Jul 21. Review.

38.

The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review.

Magnotti F, Vitale A, Rigante D, Lucherini OM, Cimaz R, Muscari I, Granados Afonso de Faria A, Frediani B, Galeazzi M, Cantarini L.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):141-9. Epub 2013 Jul 24. Review.

PMID:
23899820
39.

Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined.

Cantarini L, Vitale A, Lucherini OM, Muscari I, Magnotti F, Brizi G, Frediani B, Sebastiani GD, Galeazzi M, Rigante D.

Reumatismo. 2013 Jun 12;65(2):55-62. doi: 10.4081/reumatismo.2013.55. Review.

PMID:
23877409
40.

Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis.

Cantarini L, Lucherini OM, Vitale A, Sabadini L, Brizi MG, Frediani B, Muscari I, Galeazzi M.

Intern Med J. 2013 Jun;43(6):725-7. doi: 10.1111/imj.12163. Review.

PMID:
23745996
41.

Caution Should be Used in the Recognition of Adult-Onset Autoinflammatory Disorders: Facts or Fiction?

Cantarini L, Lucherini OM, Rigante D.

Front Immunol. 2013 Apr 23;4:96. doi: 10.3389/fimmu.2013.00096. eCollection 2013. No abstract available.

42.

Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.

Cantarini L, Brucato A, Simonini G, Imazio M, Cumetti D, Cimaz R, Bacarelli MR, Muscari I, Vitale A, Lucherini OM, Galeazzi M, Fioravanti A.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):207-12. Epub 2012 Nov 8.

PMID:
23137677
43.

S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis.

Capitani N, Patrussi L, Trentin L, Lucherini OM, Cannizzaro E, Migliaccio E, Frezzato F, Gattazzo C, Forconi F, Pelicci P, Semenzato G, Baldari CT.

Blood. 2012 Nov 22;120(22):4391-9. doi: 10.1182/blood-2012-04-425959. Epub 2012 Oct 1.

44.

Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series.

Vitale A, Lucherini OM, Galeazzi M, Frediani B, Cantarini L.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):943-6. Epub 2012 Dec 17.

PMID:
22935299
45.

Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Cantarini L, Obici L, Simonini G, Cimaz R, Bacarelli MR, Merlini G, Vitale A, Lucherini OM, Brizi MG, Galeazzi M, Fioravanti A.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S108-14. Epub 2012 Sep 25.

PMID:
22935190
46.

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.

Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R.

Autoimmun Rev. 2012 Nov;12(1):38-43. doi: 10.1016/j.autrev.2012.07.020. Epub 2012 Aug 2. Review.

PMID:
22884554
47.

The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature.

Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG, Vitale A, Frediani B, Cimaz R, Galeazzi M.

Autoimmun Rev. 2012 Nov;12(1):10-3. doi: 10.1016/j.autrev.2012.07.015. Epub 2012 Aug 2. Review.

PMID:
22878268
48.

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab.

Brizi MG, Galeazzi M, Lucherini OM, Cantarini L, Cimaz R.

Ann Intern Med. 2012 Jun 19;156(12):907-8. doi: 10.7326/0003-4819-156-12-201206190-00027. No abstract available.

PMID:
22711098
49.

Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome.

Dickie LJ, Aziz AM, Savic S, Lucherini OM, Cantarini L, Geiler J, Wong CH, Coughlan R, Lane T, Lachmann HJ, Hawkins PN, Robinson PA, Emery P, McGonagle D, McDermott MF.

Ann Rheum Dis. 2012 Dec;71(12):2035-43. doi: 10.1136/annrheumdis-2011-201197. Epub 2012 Jun 7.

PMID:
22679299
50.

Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.

Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F, Rigante D, Brambilla G, Penco S, Brizi MG, Patrosso MC, Valesini G, Frediani B, Galeazzi M, Cimaz R, Paolazzi G, Vitale A, Imazio M.

Clin Res Cardiol. 2012 Jul;101(7):525-31. doi: 10.1007/s00392-012-0422-8. Epub 2012 Feb 5.

PMID:
22311714

Supplemental Content

Loading ...
Support Center